Timothy Mack

About

Preclinical scientist with 10+ years of industrial experience with a focus on oncology therapeutics (ADCs, biologics, and small molecules). Demonstrated success in diverse areas of development including compound screening, protein purification and characterization, MOA studies, assay development, PK, PK/PD, biomarkers, and nonclinical safety. Member of cross-functional teams supporting 20+ lead generation and optimization projects including three that have entered the clinic.

Experience

• ACELYRIN, INC. (3 yrs 6 mos)
  • Senior Director Translational
    Apr 2023 - Present · 3 yrs 3 mos

  • Consultant
    Jan 2023 - Present · 3 yrs 6 mos

• Director Preclincal Development at ValenzaBio
  Oct 2021 - Jan 2023 · 1 yr 4 mos

• Scientific Director at Celgene
  Feb 2018 - Oct 2021 · 3 yrs 9 mos

• Eli Lilly and Company (New York City Metropolitan Area)
  • Principal Scientist - Quantitative Biology
    Mar 2015 - Feb 2018 · 3 yrs

    Lead an in vitro pharmacology group focused on high-throughput screening and compound characterization for large and small molecules.

  • Senior Scientist - Oncology Translational Research
    Nov 2012 - Mar 2015 · 2 yrs 5 mos

• Scientist - Nonclinical Safety at ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company
  Oct 2008 - Nov 2012 · 4 yrs 2 mos